Cargando…
The Emerging Role of N6-Methyladenosine RNA Methylation as Regulators in Cancer Therapy and Drug Resistance
N6-methyladenosine (m(6)A) RNA methylation has been considered the most prevalent, abundant, and conserved internal transcriptional modification throughout the eukaryotic mRNAs. Typically, m(6)A RNA methylation is catalyzed by the RNA methyltransferases (writers), is removed by its demethylases (era...
Autores principales: | Chen, Zhaolin, Hu, Ying, Jin, Le, Yang, Fan, Ding, Haiwen, Zhang, Lei, Li, Lili, Pan, Tingting |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9022635/ https://www.ncbi.nlm.nih.gov/pubmed/35462896 http://dx.doi.org/10.3389/fphar.2022.873030 |
Ejemplares similares
-
Role of N6-Methyladenosine Methylation Regulators in the Drug Therapy of Digestive System Tumours
por: Xia, Zhelin, et al.
Publicado: (2022) -
New roles of N6-methyladenosine methylation system regulating the occurrence of non-alcoholic fatty liver disease with N6-methyladenosine-modified MYC
por: Cheng, Wenli, et al.
Publicado: (2022) -
The emerging roles and mechanism of N6-methyladenosine (m(6)A) modifications in urologic tumours progression
por: Zhu, Wenhao, et al.
Publicado: (2023) -
The emerging roles of N6-methyladenosine RNA methylation in human cancers
por: Shen, Huafei, et al.
Publicado: (2020) -
The emerging role of RNA N6-methyladenosine methylation in breast cancer
por: Zheng, Fangchao, et al.
Publicado: (2021)